Advertise on podcast: #ChatsWithChaudhrey the Podcast

I was delighted to sit down with Philip Noone. CDir Executive Vice President Diagnostics at Biosynth as part of this years #ReflectionsandForecasts 2025/26 interview series, where I look back on the past year and look ahead to this. I asked Philip....... ◉ 01:08 Who are Biosynth and what is your role? 2025 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 ◉ 02:12 What's been happening in Biosynth Diagnostics part of the business – what were the highlights for you?  ◉ 06:06 Are there are other materials you are looking to develop other #recombinant alternatives to?  ◉ 07:19 Tell more about some of the other developments at Biosynth in 2025? ◉ 09:21 What are the main challenges your customers have faced in 2025? ◉ 11:59 Are there major differences in the regulatory environments in the different geographic regions ◉ 11:59 What were the main challenges your customers faced in 2025? ◉ 14:39 How much of a impact has #Sustainability and #AI had in the #IVD and #Diagnostics sector? ◉ 19:09 Is there anything other new developments you saw in 2025 that you would like to highlight to viewers? 2026 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 ◉ 21:56 Looking forward toward 2026, what are you thoughts in terms of how the market will be? ◉  24:28 What trends do you expect to see in 2026? ◉  27:10 What else can we expect from Biosynth in 2026? ◉  29:56 Finally what’s your New Year message to viewers? What are your thoughts on what Philip has said. Agree? Disagree? Whatever your views we would love to hear from you.  🎞 You can WATCH the podcast interview here https://lnkd.in/eTrnwawm 💻 You can learn more about Biosynth  using the link below and get in touch with Philip directly via LinkedIn! #RSKRF2526  #RSKBiosynth #diagnostics #biosynth #infectiousdiseases #Biotech #IVD #diagnosticreagents 

I had the pleasure to sit down with Del, ELRIG chair of the board before the Christmas break to kick of my #ReflectionsandForecasts2526 interview series. I asked Del.... ◉ 00:58 Quick overview of ELRIG and your history with ELRIG? ◉ 02:20 What is the role of Chair of the board and why you were happy to do it? 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 2025 ◉ 03:59 What have been some of the highlights for ELRIG this year? ◉ 06:48 I understand #DrugDisovery was a record breaking year this year? ◉ 07:39 You had your first event in the US this year. How did that go and what are your plans going forward? ◉ 09:41 How do think the market has been in 2025 for the UK and Europe? ◉ 12:10 What have seen as the hot topics in 2025 when putting together the event programs last year? 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 2026 ◉ 15:09 Looking ahead to 2026 what are your views from a macro level in terms of the Life Science sector in the UK and Europe? ◉ 18:01 What do you think Start-Ups are not doing to attract investors?  ◉ 21:10 Which technology trends apart from AI, and CGT which we discussed earlier people  should look out for? ◉ 25:27 What can we expect from ELRIG for 2026? What are your thoughts on what Del said re 2025 and 2026? Agree? Disagree? we would love to get your views.  🎞 You can WATCH the podcast interview here https://lnkd.in/eAJz55qy You can learn more about  ELRIG and all their upcoming events here https://elrig.org/ #RSKELRIG #RSKRF2526 #RSKJan26 

I caught up with Ignacio in Jan to get his thoughts and predictions on what is happening in the #CellandGeneTherapy space and learn more about #CellReady I asked Ignacio ... ◉  Before we look back at 2024 Ignacio would you mind giving viewers a quick overview of CellReady, who you are and what your companies products/services are? 00:58 ◉ Who are G-Rex and what is the relationship between CellReady and ScaleReady? 01:46 ◉  First question re 2024, Ignacio how would you describe 2024 in one word and why?02:45 ◉ What have been some of the highlights for CellReady this year? 05:16 ◉ What challenges has the industry faced this year? 06:28 ◉ What are some of the key trends you have seen in #CellandGeneManufacturing? 10:29  Looking ahead to 2025 ◉ On a macro level how positive are you with regards investment in the #CGT space? 12:33 ◉ What challenges to you think the sector faces in the coming year? 14:10 ◉ Anything new in terms of innovation or trends we should be looking out for? 15:57 ◉ What can we expect from CellReady in 2025? 18:28 ◉ Where can people meet CellReady in the near future? 19:53 ◉ Finally, what is your message for viewers watching this for 2025? 21:12 🎞 You can WATCH the interview here https://lnkd.in/eS7fU96y 💻 Learn more about ScaleReady and CellReady™ here https://lnkd.in/egKNJGC5 #RSKRF2425 #RSKJan25 #RSKCellReady #CellTherapy #Pharma #GeneTherapy #RegenerativeMedicine #AllianceforRegenerativeMedicine #BiotechInnovation #LifeSciences  #ResearchSupport #HoustonBiotech #CARTcellTherapy #Biotechnology #CancerResearch #AdvancedTherapies #Immunotherapy CellReady™ ScaleReady Wilson Wolf Manufacturing, LLC

I sat down with #CAI's VP Marketing and Consulting Services, David Shenberger and Chief Strategy Officer Alice Redmond to look back at 2022, and get some predictions for 2023 We discussed #consolidationofassets and pipelines, #ATMPS, #RegulatoryFrameworks, #AI #Pharma4.0, #ChatGPT, #pharmapricing, #outsourcing and a lot more. I asked.... 2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 • Can you give me a quick overview of CAI? 00:43 • One word to describe 2022 and why? 01:49 • What were some of CAI key achievements in 2022? 03:00 • Have clients expectations changed since the pandemic? 04:19 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 06:00 • Does the growth of ATMPS changed how they work with clients? 09:07 • Are there any areas you think the industry could improve? 10:36 2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 • What are your predictions for the #LifeSciences, #Pharma and #BioPharma in 2023? 12:06 • What developments and trends do you expect to see/predict for #PharmaManufacturing? 16:55 • What can we expect CAI in 2023? 17:44 • Finally, what last thoughts would you like to leave viewers with for 2023? 20:45 🎞 WATCH the interview here https://lnkd.in/eMWuGXmF Feel free to leave any questions or comments for Alice or David below. You can learn more about CAI at www.cagents.com

I caught up with Tina as part of my #ReflectionsandForecasts 22/23 interview series. we covered a huge range of topics, include, #SupplyChain, #AI, New Technologies, and lots more. Check it out! I asked Tina... 2022 Reflections • Can you give me a quick overview of AAPS? 01:30 • Has AAPS membership changed with the growth of #ATMPS? 02:52 • One word to describe 2022 and why? 05:04 • What were some of AAPS’s achievements in 2022? 06:36 • Did the pandemic force AAPS to become more of a 365 association rather than just a major annual event organiser? 08:49 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 10:13 • Did the visitor profile change for #PharmSci360 in 2022? 12:10 • Are there any areas you think the industry could improve? 14:42 2023 Forecasts • What are your predictions for BioPharma/ Pharma in 2023? 16:44 • What developments and trends do you expect to see/predict in the Drug Development? 18:57 • How important are Sustainability and AI as issues for AAPS members? 20:53 • What can we expect from AAPS in 2023? 25:26 • Finally, what last thoughts would you like to leave viewers with for 2023? 28:13 🎞 WATCH the interview here https://lnkd.in/enQNjFHM Please feel free to leave any questions or comments below . You can learn more about #AAPS and their upcoming events at www.aaps.org/ 🎞 Watch my interview with Tina at Octobers #PharmSci36022 here https://lnkd.in/eQdjrwyZ

I sat down last week with ScaleReady's Global Director Commercial Operations, Josh Ludwig to get thoughts on the past 12 months and get some predictions for 2023. I asked Josh... • How was Phacilitates Advanced Therapies Week? 00:49 2022 Reflections • Can you give me a quick overview of ScaleReady? 01:29 • One word to describe 2022 and why? 02:53 • What were some of ScaleReady's key achievements in 2022? 04:49 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 07:56 • Are there any areas you think the industry could improve? 10:28 2023 Forecasts • What are your predictions for the Life Sciences and BioPharma in 2023? 12:53 • How will Sustainability and AI impact ATMP and Cell Therapy sector? 14:52 • What can we expect from ScaleReady in 2023? 20:04 • Will ScaleReady be looking for partners to cooperate with in 2023? 22:39 • Finally, what last thoughts would you like to leave viewers with for 2023? 25:14 🎞 WATCH the interview here https://lnkd.in/erpxwfUh Feel free to leave Josh any comments and questions below. You can meet Josh and the team at ScaleReady at numerous events throughout he year, including this months CAR-TCR Summit Europe at the Excel in London, and learn more at www.ScaleReady.com

I had the pleasure of sitting down with #SLAS's CEO Vicki Loise and the new SLAS president Jan Lichtenberg (also CEO of InSphero ) as part of my #ReflectionsandForecasts 2022/23 interview series recently. We had an in depth conversation where I asked them... 2022 Reflections • Can you give me a quick overview of SLAS? 01:27 • One word to describe 2022 and why? 02:06 • What were some of SLAS’s achievements in 2022? 04:39 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 07:45 • Are there any areas you think the industry could improve? 10:41 2023 Forecasts • What are your predictions for Life Science/BioPharma/ Pharma in 2023? 12:30 • What developments and trends do you expect to see/predict in Lab Automation? 17:04 • What can we expect from SLAS in 2023? 20:40 • Finally, what last thoughts would you like to leave viewers with for 2023? 24:06 🎞 Y0ou WATCH  the interveiw here https://lnkd.in/eJT5NMnQ If you have any questions for Vicki or Jan re SLAS or Lab Automation, feel free to put them in the comments below. You can learn more about SLAS here at www.SLAS.org and Learn more about SLAS 2023 in San Diego Feb 25-March 1 here https://lnkd.in/eDCMeGbV See you at #SLAS2023 in San Diego at the end of the month!!!

I sat down with Jane Lyons, Country Manager, PharmaLex Ireland, and  European Co-Ordinator for Quality Management and Compliance, as part of my ongoing #ReflectionsandForecasts 2022/23 interview series. We covered a wide range of topics including #Hybridworking, #Onshoring, #BREXIT, #ATMPS, #AI, #Blockchain, #ANNEX1, #outsourcing and more. I asked her.... 2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬  •   Can you give me a quick overview of #PharmaLex? 00:55 •   One word to describe 2022 and why? 02:04 •   What were some of #PharmalexIrelands key achievements in 2022? 03:10 •    What has been client reactions to PharmaLex's continuing the hybrid working model 04:42 •   Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 06:24 •    How easy it for countries to onshore their #Pharma #API manufacturing? 07:52 •    How much impact has BREXIT had on Pharma in the UK and Europe? 08:59 •    Are there any areas you think the industry could improve? 10:37   2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 •   What are your predictions for the #LifeScience, #Pharma and #BioPharma in 2023? 12:16 •  What developments and trends do you expect to see/predict in terms of regulation?  14:11 •   What can we expect from Pharmalex Ireland in 2023? 16:19 •   What is Janes view in terms of funding in the Pharma/ BioPharma in Europe in 2023? 17:25 •  Finally, what last thoughts would you like to leave viewers with for 2023? 19:36 🎞 You WATCH the interview here https://lnkd.in/e6bX49r2 Please leave any questions or comments for Jane below.  You can find out more about PharmaLex Ireland at https://lnkd.in/dt_Fi9Vn You can also reach out to Jane via LinkedIn and email her at [email protected] 🎞 You can see Janes Reflections and Forecasts for last year here  https://lnkd.in/eGtP9gxz 

🎞 #ChatsWithChaudhrey The Podcast S6E001 #ReflectionsAndForecasts 2024/2025 E1 Here's  my first #ReflectionandForecasts interview getting SLAS's CEO Vicki Loise and VP Philip Gribbon who is also Head of Discovery Research at Fraunhofer Institute for Translational Medicine and Pharmacology (Fraunhofer ITMP) to give me their thoughts on 2024 and their predictions for 2025. I asked Vicki and Philip ◾ Before we look back at 2024 Vickie would you mind giving viewers a quick overview of SLAS, who you are and what your mission is? 01:13 ◾ First question re 2024, Vickie, Philipp how would you describe 2024 in one word and why? 03:22 ◾ What have been some of the highlights for SLAS this year? 06:39 ◾ What challenges have SLAS and the industry faced this year? 09:47 ◾ What are some of the key trends you have seen emerge in the sector? 13:18   Looking ahead to 2025 ◾ On a macro level how positive are you with regards investment in the sector? 18:22 ◾ What challenges to you think the sector faces in the coming year? 22:22 ◾ Anything new in terms of innovation or trends we should be looking out for?25:12 ◾ What can we expect from SLAS in 2025? 29:18 ◾ Have #SLAS thought about doing events outside of North America and Europe 32:59 ◾ Finally, what is your message for viewers watching this for 2025? 34:39 You can learn more and get you tickets below for; 🎫 #SLASEurope2025 Hamburg May 20-22 https://lnkd.in/eR76kEY2  💻 Learn more about SLAS (Society for Laboratory Automation and Screening) here https://www.slas.org 🎞 Subscribe to my YouTube Channel RSK Life Science Media here https://lnkd.in/gdthyRu where I host over 2000 interviews at shows & over zoom, with experts & companies across the Life Science Pharma value chain, from #drugdiscovery to #drugdelivery. 🤝🏻 Check out my latest 2025 #LifeScience #Pharma, #BioPharma  #CellandGeneThearpy Events here https://lnkd.in/eWcG-nmG #RSKRF2425 #RSKJan25 #RSKSLAS #RSKSLAS25 #LabAutomation #LabScreening #DrugDiscovery #SamplePrep 

 I caught up with Annabel this week as part of my #ReflectionsandForecasts,series. We discussed #Tio2, #supplychain, #forecasting,  #drugsecurity, #wellness and more. I asked Annabel.... 2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬  • Can you give me a quick overview of Colorcon? 00:44 • One word to describe 2022 and why? 01:05 • What were some of Colorcon’s achievements in 2022? 02:07 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 03:09 • How did Colorcon overcome the challenges around Supply Chain? 03:52 • Are there any areas you think the industry could improve? 04:29 2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 • What are your predictions for #Pharma in 2023? 05:17 • What developments and trends do you expect to see/predict in #TabletCoatings and #DrugSecurity, and what can we expect from Colorcon in 2023? 06:12 • Finally, what last thoughts would you like to leave viewers with for 2023? 07:07 If you have any questions for Annabel please leave them below in the comments. 🎞 Watch  the interview here https://lnkd.in/eVM_YCuR You can find out more about #Colorcon and their solutions at www.colorcon.com

2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 • Can you give me a quick overview of ApiJect? 00:512 • What were some of ApiJect achievements in 2022? 03:21 • One word to describe 2022 and why? 05:33 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 05:44 • Are there any areas you think the industry could improve? 09:06 2023 Forecasts • What are your predictions for BioPharma/ Pharma in 2023? 10:36 • What developments and trends do you expect to see/predict in the use of Blow Fill seal and Drug delivery for Vaccines, and what can we expect from ApiJect in 2023? 16:20 • Finally, what last thoughts would you like to leave viewers with for 2023? 18:30 🎞 Watch the interview here https://lnkd.in/ew6cdqPf You can learn more about ApiJect by visiting www.Apiject.com This post is sponsored by ApiJect

I sat down with Julie Waras Brogren. Deputy CEO for Biotech Ascelia Pharma as part of my #ReflectionsandForecast20222023 interview series. I asked Julie... 2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 ✺ For those who are not familiar, please give us a quick introduction to you and Ascelia Pharma. 01:05 ✺ In what way is your technology innovative and how does it differ from other products on the market? 02:22 ✺ What is Orviglance and what stage are you currently at with Orviglance? 05:01 ✺ One word to describe 2022 and why? 05:23 ✺ What were some of company's key achievements in 2022? 06:18 ✺ Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? Are there any trends and challenges you are noticing as an emerging biotech company? 07:54 ✺ Has it been difficult to get investment for non-covid related #drugdevelopment? 09:35 ✺ Is Ascelia’s #ClinicalTrials program global and was it impacted by #Covid? 10:17 ✺ Are there any areas you think the industry could improve? 11:33 2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 ✺ What are your predictions for #LifeScience/ #Pharma/ #BioPharma in 2023? 12:57 ✺ What developments and trends do you expect to see/predict in #orphanoncology treatments? 14:42 ✺Lets look more specifically at Ascelia in 2023 and beyond. As a #biotech with a developing portfolio, where is your focus, what are your 2-3 year objectives? 17:22 ✺ In terms of the future, what partnerships and collaborations would be ideal for advancing the company’s growth? 19:14 ✺ Finally, what last thoughts would you like to leave viewers with for 2023? 22:09 Feel free to leave any questions or comments for Julie below. 🎞 You can WATCH the interview here https://lnkd.in/enT7WtC3 You can learn more about #AsceliaPharma at www.Ascelia.com

I was delighted to catch up with Cherwell Laboratories MD Andy Whittard as part of this years #RefelectionsandForecasts interview series. We talked about Cherwell Laboratories, their achievements in 2022,  their "Delivery Knowledge" platform, meeting the challenges in 2022, the impact of #Annex1 on #EnviromentalMonitoring, #ContinuousMonitoring, #supplychain, co-operation, and sustainability. 2022 Reflections  • Can you give me a quick overview of Cherwell Laboratories? 00:39 • One word to describe 2022 and why? 01;50 • What were some of Cherwell Laboratories key achievements in 2022? 04:40 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 05:29 • How have Cherwell managed customers expectations due to the challenges around Supply Chain issues? 08:03 • Did Andy think that dealing with the Covid19 period helped the business become more "agile"? 09:33 •  When Annex 1 came out in August was it what Andy expected it to be? 11:33 • Are there any areas you think the industry could improve? 13:13  2023 Forecasts • What are your predictions for the Life Science/Pharma/ BioPharma in 2023? 15:14 • What developments and trends do you expect to see/predict in contamination control with the new Annex One Updates? 17:49 • Where does  Andy think AI and Machine learning can help in Environmental Monitoring?24:14  • What can we expect from Cherwell Laboratories 2023? 25:52 • Finally, what last thoughts would you like to leave viewers with for 2023? 29:09 You can check out #Cherwells  online EU #GMP and #Annex resources page which provides further background and insight on the latest regulatory update governing the manufacture of #sterile #medicinalproducts, at https://lnkd.in/geW5f2EV and learn more about Cherwell Laboratories at www.cherwell-labs.co.uk You can WATCH the interview here https://lnkd.in/ecsqJjK6

Here's Episode 2 of #ReflectionandForecasts2223 series with my good friend Oliver Stauffer CEO of #PTI We spoke about the impact of #ATMPs and #Biologics on #ClosedContainerIntegrity Testing, The growth of #CDMO's, #SupplyChain, #AI, #MachineLearning, #Automation, #Collaboration, #Annex1 and more. I asked Oliver... 2022 Reflections • Can you give me a quick overview of #PTI? 00:46 • One word to describe 2022 and why? 01:32 • What were some of PTI key achievements in 2022? 02:50 • Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 03:59 • How have the growth of the Biologics and ATMP impacted the technologies required for #CCIT? 05:53 • Are there any areas you think the industry could improve? 07:25 2023 Forecasts • What are your predictions for #Pharma/ #BioPharma in 2023? 08:26 • Did Oliver think the trends in 2023, would be different for North America and Europe due to Annex 1? 9.29 • What developments and trends do you expect to see in #CCITesting and the impact Annex 1 will have in that area? 11:53 • What role will AI and Machine Learning impact on #CCIT? 13:17 • Does Oliver think collaborations will continue in the industry? 14:38 • What can we expect from PTI in 2023? 16:57 • Finally, what last thoughts would you like to leave viewers with for 2023? 18:26

I am delighted to be kicking off this years #ReflectionsandForcasts series with Carsten Press SVP Key Account Management, Supply Chain and Marketing, CDMO #VetterPharma We had a really interesting discussion covering #Sustainability, #Robotics, the role of #CDMO's, #SupplyChainSecurity, #collaboration, and more. I asked Carsten... 2022 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬  ✹ Can you give me an overview of yourself and your role at Vetter Pharma? 00:58 ✹ Can you give me a quick overview of Vetter Pharma? 01:45 ✹ One word to describe 2022 and why? 03:13 ✹ How has Vetter changed since the pandemic? 03:51 ✹ What were some of Vetter's key achievements in 2022? 05:12 ✹ Looking back at 2022 what industry trends, stood out for you? 07:03 ✹ Has the role of CDMO's changed over the past few years? 08:26 ✹ Are there any areas you think the industry could improve? 10:34 ✹ What has driven Pharma's large carbon footprint? 11:20 2023 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐬 ✹ What are your predictions for the #LifeScience/#Parma sector in 2023? 12:17 ✹ What developments and trends do you expect to see/predict in the area of Pharma manufacturing? 13:34 ✹ How have Vetter ensured #securityofsupply? 15:18 ✹ What is the alliance with Rentschler Biopharma SE, how is it going to work, and does Carsten believe that collaboration with other companies is the way forward in Pharma? 18:20 ✹ What can we expect from Vetter Pharma in 2023? 21:39 ✹ Finally, what last thoughts would you like to leave viewers with for 2023? 23:01 You can see  Vetter Pharma  sustainability report here https://lnkd.in/ea89cRXw nd learn more about Vetter Pharma here https://lnkd.in/eeGkdGPf #RSKVetterPharma #ReflectionsandForecasts20222023 #DrugDiscoverytoDrugDelivery, #Pharma , #Biopharma , #Biotech,  #ClinicalManufacturing #DrugManufacturing #PharmaManufacturing You can watch the video version of this interview here  https://lnkd.in/eUzzs-HV